20th International Academy of Periodontology (IAP)

Biennial Joint Scientific
Conference

9th Malaysian Society of Periodontology (MSP)

2025/10/03-04
Connexion Conference & Events Centre (The Vertical)
REGISTER
Global Perspectives on Periodontology:
Leveraging Diverse Approaches for
Enhanced Patient Care

Dateline for Abstract extended to 15 July
Dateline for Early bird extended until 30 July

List of Speakers

Prof. Dr. Niklaus P. Lang 🇨🇭(Switzerland)
Yuhaniz Ahmad Yaziz 🇲🇾 (Malaysia)
Alpdogan Kantarci 🇺🇸 (USA)
Hatice Hasturk 🇺🇸 (USA)
Mark Bartold 🇦🇺 (Australia)
Rasidah Ayob 🇲🇾 (Malaysia)
Wim Teughels 🇧🇪 (Belgium)
Thomas Van Dyke 🇺🇸 (USA)
Shogo Takashiba 🇯🇵 (Japan)

Conference Schedule

Day 1
03/10/2025
conf-logo
07:45am
Registration
MSP
Registration
conf-logo
8:20am-8:30am
Welcome Speech
Committee
Welcome Speech
Welcome speech by committee members
conf-logo
8:30am-8:35am
Perio-systemic Relationship: Enhancing Periodontal Outcomes through Effective Risk Management
Rathna Devi Vaithilingam/Joerg Meyle as Moderators
SESSION 1
conf-logo
8:35am-9:00am
Periodontitis and Non-Communicable Diseases: A Bidirectional Challenge and a Call for Integrated Care
Yuhaniz Ahmad Yaziz 🇲🇾
L1
Non-communicable diseases (NCDs) are responsible for over 43 million deaths annually, accounting for approximately 75% of non-pandemic-related mortality worldwide. Although primarily addressed within the context of systemic health, NCDs and periodontitis exhibit significant overlap in pathophysiology, risk factors, and clinical outcomes. Periodontitis is a chronic, multifactorial inflammatory disease associated with microbial dysbiosis and host immune response. In its severe form, it affects approximately 11% of the global adult population and is increasingly recognized as a consequence and potential contributor to systemic inflammatory burden. Given this interconnectivity, periodontists are uniquely positioned to play a central role in early detection, risk factor modification, and prevention of systemic diseases through integrated oral-systemic care models. As global health policy evolves, initiatives such as the WHO Bangkok Declaration 2025–2030 aim to formally incorporate oral health into NCD strategies, reinforcing the urgent need for collaborative care between dental and medical professionals. This presentation will explore the interplay between periodontitis and major NCDs, focusing on the clinical and public health implications of interdisciplinary prevention and management and highlighting the opportunity to redefine oral healthcare within the broader framework of systemic health.
conf-logo
9:00am-9.25am
Inflammatory and Microbiological Basis of The Link between Oral and Neurodegenerative Diseases
Alpdogan Kantarci 🇺🇸
L2
The oral cavity is a specialized environment with one of the most diverse microbial ecosystems and mucosal immune responses. Oral inflammatory diseases, including periodontal pathologies, have a profound impact on distant organs and are linked with more than 50 systemic diseases. An infecto-inflammatory process can be a mechanism for disseminating the oral bacteria to distant organs, where the host’s cells can actively be involved in transporting the microbial cargo. This presentation will focus on the multi-dimensional mechanism of the link between oral and neurodegenerative diseases.
conf-logo
9:25am-9.50am
Diabetes, Cardiovascular Diseases and Periodontal Diseases
Hatice Hasturk 🇺🇸
L3
Periodontal disease is among the most prevalent non-communicable diseases globally and is increasingly recognized for its bidirectional relationship with systemic conditions. Systemic diseases can elevate the risk, severity, and progression of periodontal disease, while periodontitis itself may adversely influence systemic health and modify the clinical course of systemic diseases, especially in vulnerable populations. Type 2 Diabetes Mellitus (T2DM) is characterized by chronic hyperglycemia, which induces a systemic inflammatory state and contributes to the development of diabetic complications, including both macrovascular (e.g., cardiovascular disease) and microvascular (e.g., neuropathies) conditions. Hyperglycemia is a well-established risk factor for periodontal disease, exacerbating inflammatory and tissue-destructive processes in the oral environment. Similarly, cardiovascular disease (CVD), particularly atherosclerosis and its ischemic complications such as myocardial infarction and stroke, remains a leading cause of morbidity and mortality worldwide. Atherosclerosis is a chronic inflammatory condition marked by vascular inflammation and lipid accumulation, and compelling epidemiological and clinical evidence now supports periodontitis as an independent risk factor for CVD. Our research has demonstrated that periodontal inflammation contributes to systemic disease by promoting a chronic inflammatory burden. Specifically, periodontal disease may exacerbate both diabetes and atherosclerosis through increased systemic levels of pro-inflammatory mediators. This lecture will present the latest evidence linking periodontal disease with diabetes and cardiovascular disease. It will explore how chronic periodontitis may serve as an independent modifiable risk factor for these systemic conditions. We will also examine the interplay between microbial dysbiosis and host susceptibility, highlight the role of specialized pro-resolving mediators in inflammation resolution, and discuss the potential of personalized periodontal medicine. Emphasis will be placed on the use of advanced diagnostics and targeted therapeutics to improve outcomes through precision care.
conf-logo
9:50am-10.15am
Future direction of Periodontal medicine
Mark Bartold 🇦🇺
L4
The term “Periodontal Medicine” first emerged in 1996 to define a rapidly emerging branch of periodontology focusing on the relationship between periodontal health or disease and systemic health or disease. Now, after almost 30 years of very active research a number of conditions have been very strongly associated with periodontal disease. However, there have also been many studies that have trivialized this field leading to some 120 conditions reported to be associated with periodontal disease. In this presentation a method for determining the potential significance of a periodontal/systemic condition (Disease Association Check List) will be discussed. There will be need to understand biological mechanisms, disease causality and syndemic relationships. Simplistic epidemiological methodology is unlikely to provide insights into causal mechanisms oral diseases or oral-systemic relationships. Future studies should consider the bidirectional relationships of these associations and how treatment of both periodontal disease and condition in question can impact on each other. There are many issues confronting the field including the reporting of spurious and trivial associations, the significance of “responder” and “non-responder” individuals and the emergence of AI technologies. The future will focus on the concept that the inflammatory periodontal diseases are systemic diseases. There is urgent need to focus attention on a limited number of conditions for which there is very strong evidence to support not only an association but also treatment outcome effects.
conf-logo
10:15am-10:35am
Panel - discussion
Forum
conf-logo
10:35am-10:40am
Gift / Photo
conf-logo
10:40am-11:10am
COFFEE BREAK & TRADE BOOTH VIEWING
conf-logo
11:10am-11:15am
Contemporary Approaches in Periodontal Care
Chia Wei Cheah/Anton Sculean as Moderators
SESSION 2
conf-logo
11:15am-11:40am
Current concepts in the use of mechanical debridement in periodontitis
Raluca Cosgarea 🇩🇪
L1
Mechanical debridement remains a cornerstone in the non-surgical treatment of periodontitis, aimed at disrupting and removing subgingival biofilm and calculus to arrest disease progression. This presentation reviews contemporary perspectives on mechanical debridement, focusing on advancements in instrumentation, treatment protocols, and clinical outcomes. Emphasis will be placed on the integration of air-polishing devices and new adjunctive measures, the role of full-mouth disinfection protocols, and the importance of personalized, stage- and grade-based approaches in line with the 2017 World Workshop classification. By synthesizing recent research and clinical guidelines, this session aims to provide clinicians with an updated, evidence-based framework for optimizing periodontal care through mechanical debridement.
conf-logo
11:40am-12.05pm
Management of Perio Endo-Perio Lesion
Shogo Takashiba 🇯🇵
L2
A combined endodontic-periodontal (endo-perio) lesion can be successfully managed with a strategic, evidence-based approach tailored to its primary etiological source. In modern clinical practice, the first step is to address the main origin of infection. For a lesion of endodontic origin (such as a necrotic pulp with drainage through the periodontium), thorough root canal therapy is performed to eliminate the pulpal infection. This often results in significant periodontal healing, and any remaining periodontal defect can subsequently be managed with scaling, root planing, and regenerative periodontal therapy. Conversely, if the lesion is primarily periodontal in origin (for example, advanced periodontal disease extending toward the apex), periodontal therapy takes priority. This includes deep scaling and root planing, with surgical regenerative procedures—such as guided tissue regeneration—if needed to control the infection. Root canal treatment is then provided if the pulp has become non-vital. An integrated and coordinated approach is required for truly combined lesions (involving both pulpal and periodontal disease). In such cases, endodontic therapy is paired with appropriate periodontal treatment to address both components, and regenerative techniques such as bone grafting or biomaterials are often employed after infection control to restore lost structures and re-establish healthy attachment. Looking ahead, several promising strategies are emerging. Intentional replantation—extracting the tooth, managing it extraorally, and replanting it with regenerative adjuncts—is being re-evaluated as a potential means of saving severely compromised teeth. Additionally, minimally invasive innovations include bioactive materials that support regeneration, local drug delivery systems for targeted antimicrobial or growth factor release, and host-modulation therapies to enhance the body’s healing capacity. Ultimately, both current and future approaches aim to promote healing and regenerate lost tissues, preserving the natural tooth and periodontal structures, and improving long-term outcomes in these complex endo-perio cases.
conf-logo
12:05pm-12.30pm
Probiotics in Managing the Oral Microbiome
Wim Teughels 🇧🇪
L3
The prevention and treatment of oral diseases like periodontitis and peri-implantitis traditionally focus on biofilm removal, often combined with antimicrobials. However, antimicrobial resistance has become a global challenge, highlighting the need for alternative approaches. In recent years, probiotics have emerged as a promising adjunct in oral healthcare. Despite initial skepticism, clinical trials have demonstrated their effectiveness in preventing and managing periodontitis; with growing, though more limited, evidence for peri-implantitis. This lecture will explore the role of probiotics in modulating the oral microbiome to promote health, addressing both scientific evidence and ongoing concerns about their clinical application. Additionally, practical guidelines for selecting and implementing probiotics in daily patient care will be provided. By the end of the session, attendees will gain a clear understanding of the potential of probiotics in oral disease management and how to integrate them effectively into periodontal and peri-implant treatment strategies.
conf-logo
12:30pm-12:50pm
Panel - discussion
Forum
conf-logo
12:50pm-12:55pm
Gift/Photo
conf-logo
12:55pm-2:30pm
LUNCH & TRADE BOOTH VIEWING
conf-logo
2:30pm-2:35pm
Reconstructive advancements in periodontal therapy
Renukanth Raman/Raluca Cosgarea as Moderators
SESSION 3
conf-logo
2:35pm-3:00pm
Three-Dimensional Printing and Advancement in Periodontal Biomaterial
Saso Ivanovski 🇦🇺
L1
Various approaches been proposed for bone and periodontal regeneration, yet treatment outcomes remain unpredictable in challenging clinical scenarios. Particularly promising are bioengineering approaches, commonly involving a combination of different cell types, scaffolds and biologically active molecules. Among these, scaffolds are of particular interest as they address the key issues of space maintenance and control over the healing events within the presenting defect. This lecture will describe novel resorbable personalized (patient-specific) scaffold fabrication using 3D printing, for the regeneration of bone and periodontal defects.
conf-logo
3:00pm-3:25pm
Periodontal regenerative/ reconstructive management of intrabony defects
Andreas Stavropoulos 🇸🇪
L2
conf-logo
3:25pm-3:50pm
Periodontal Surgeries in the Ministry of Health Malaysia: Applications of Blood-Derived Products
Rasidah Ayob 🇲🇾
L3
This session presents clinical experiences on the use of blood-derived products in various periodontal surgical procedures within the Ministry of Health Malaysia. These products serve as a vital halal alternative to porcine-based biomaterials, addressing the needs of Muslim patients. Highlighted cases include challenging surgeries such as periodontal regeneration, peri-implantitis defect reconstruction, guided bone regeneration, sinus membrane repair, surgical endodontics, and post-trauma bone reconstruction in pediatric patients. The outcomes demonstrate enhanced healing, reduced postoperative morbidity, and promising success even in cases with initially questionable prognosis.
conf-logo
4:10pm-4:15pm
Panel - discussion
Forum
conf-logo
4:10pm-4:15pm
Gift/Photo
conf-logo
4:15pm-6:00pm
TEA BREAK & TRADE BOOTH VIEWING/ BOARD MEETING IAP MEMBERS
conf-logo
7:30pm-10:00pm
Gala dinner for delegates
Committee
Day 2
04/10/2025
conf-logo
8:30am-9:15am
Save the tooth: Our Mission
Niklaus Lang Moderator: Shogo Takashiba
Keynote Lecture
Answering the question of maintaining a compromised tooth or extracting it and maybe replacing it with an implant is certainly not an easy task and probably best dealt with by stating: "It depends on a variety of aspects both patient-related, skill of the therapist-related and economic in nature". However, for the practicing dentist, a relatively reliable answer is of utmost importance, especially when reconstructions are planned to restore adequate function, obtain satisfying esthetics and obtain and maintain oral health. Therefore, the question will be addressed for various situations: For the healthy tooth with an almost intact periodontal support, for the periodontally compromised, but successfully treated abutment tooth, for the devitalized, but root canal treated tooth, for the endodontically compromised tooth with periapical pathology. These discussions will emphasize the importance of maintaining natural teeth even if they are affected by pathological findings. Post therapeutic treatment prognoses are well documented, especially for survival and complication rates of fixed partial dentures on tooth abutments, on implants and on both combined tooth and implant abutments. The major question is not to discuss the alternative between tooth abutments versus implant abutments, but to discuss predictability and longevity of teeth following active periodontal or endodontic therapy. In that respect, implants do not provide a higher value to the patient. They are not chosen to replace teeth, but to help replace already missing teeth. Indeed, our mission is to save teeth. It has to be realized that the long- term documentation of implant survival and complication rates are at its best 10 years old and that very few of the systems sold today have more than 5-year data to offer. However, even for teeth jeopardized by periodontal or endodontic conditions the literature provides a number of long-term studies to answer the above proclaimed question with high reliability always considering the single patient situation with great respect. Let us face the challenge and keep the teeth rather than extracting them prematurely as they have a documented higher longevity than do oral implants.
conf-logo
9:15am-9:20am
Future Perspectives in Periodontology: Shaping Tomorrow's Practices and Innovations
Masfueh Razali/ Alpdogan Kantarci as Moderators
Session 4
conf-logo
9:20am-9:45am
Microbe in perio/omics
Purnima Kumar 🇺🇸
L1
As dentists, it behoves us to not only treat oral diseases, but to treat the patient. This requires a comprehensive understanding of how systemic and environmental factors may influence oral health, as well as how oral diseases and their management can in turn impact overall health. This presentation will feature over 20 years worth of research invested in investigating the circular relationship between oral health and overall health, and the interplay between genetic influences, lifestyle habits and systemic health.
conf-logo
9:45am-10:10am
Immuno-Modulation in Periodontology
Thomas Van Dyke 🇺🇸
L2
Periodontitis, the most common inflammatory disease of man, is an infectious/inflammatory disease associated with dysbiosis of the commensal oral microbiome. The mildest, reversible form of the disease, gingivitis, is ubiquitous, affecting >90% of people, but periodontitis, with irreversible tissue destruction, affects more than 47% of the US population. Endogenous lipid mediators of resolution, including analogues under development for human use, have provided new approaches for the management of periodontitis through host response modulation using specialized proresolving lipid mediators (SPMs). Preclinical studies have demonstrated that SPMs are potent when topically applied in the prevention and treatment of periodontitis, demonstrating significant regeneration of soft tissues and reduction in bone loss to disease. Clinical trials in humans reveal these compounds are safe and a specific lipoxin analog reduces gingivitis and established periodontitis. These first in human studies demonstrate safety and efficacy of a pro-resolving mimetic for the treatment of periodontal diseases in man. Newer studies of bone grafting materials combined with SPMs reveal more complete and rapid new bone formation, demonstrating great potential for its clinical use in periodontology.
conf-logo
10:10am-10:35am
Regenerative Minimally Invasive Non-Surgical Therapy for the Treatment of stage III and IV Periodontitis Patients
Ahmed Gamal 🇪🇬
L3
While conventional non-surgical periodontal therapy (CNST) remains a cornerstone in managing mild to moderate periodontitis, its effectiveness can be limited in advanced cases. In stages III and IV periodontitis, deep residual pockets and increased tooth mobility often persist despite CNST—frequently necessitating the use of splints. Minimally invasive non-surgical techniques (MINST) have emerged as a promising alternative, offering improved patient comfort and potentially enhanced clinical outcomes. However, there remains a need to further refine these approaches, particularly in the context of splinted teeth, where evidence on long-term outcomes is still evolving. This presentation will explore an innovative strategy: the introduction of space fillers, with or without biologics, applied through a minimally invasive approach, and to evaluate the clinical outcomes of MINST compared to CNST in the treatment of splinted teeth affected by stage III and IV periodontitis.
conf-logo
10:35am-10:55am
Panel - discussion
Forum
conf-logo
10:55am-11:00am
Gift/Photo
conf-logo
11:00am-11:15am
COFFEE BREAK & TRADE BOOTH VIEWING
conf-logo
11:15am-11:20am
Scientific and Clinical Updates in Implant Therapy
Norul Husna/Ahmed Gamal as Moderators
Session 5
conf-logo
11:20am-11:45am
(Peri-) Implant Disease Risk Assessment: The Practicality
Joerg Meyle 🇩🇪
L1
Implant therapy has become an integral component of modern dental treatment, offering reliable and predictable outcomes. However, the long-term success of dental implants is influenced by a variety of systemic and local factors—some of which are modifiable and can be managed proactively. Systemic conditions such as periodontitis and diabetes mellitus have been identified as significant systemic risk factors for early peri-implant inflammation. Locally, factors such as accessibility for maintenance of optimal oral hygiene play a critical role in disease prevention. This lecture will highlight the importance of a comprehensive, preventive approach to implant care, beginning even before implant placement. Primordial and primary prevention strategies—including the appropriate selection of implant types (bone- or tissue-level)—will be discussed, alongside the vital role of individualized maintenance protocols in secondary prevention. Emphasis will be placed on risk assessment using the Implant Disease Risk Assessment (Heitz-Mayfield, 2020) tool, which provides clinicians with a structured framework to tailor follow-up intervals based on individual patient profiles. Drawing from the current clinical guidelines of the European Federation of Periodontology (EFP), this session will explore these key concepts through various clinical scenarios, offering practical insights into maintaining peri-implant health and optimizing long-term treatment outcomes.
conf-logo
11:45am-12:10pm
Implant Therapy in Periodontally Compromised Patients
Jeanette Chua 🇲🇾
L2
Over the past two decades, dental implants have seen exponential growth in adoption across the profession, building on a foundation established nearly 60 years ago. As implant technologies and surgical techniques continue to evolve rapidly, they have significantly simplified the clinical process—sometimes to the point where diagnosis and comprehensive treatment planning may be overlooked. This becomes especially critical when treating periodontally compromised patients, where the complexity of care demands an integrated, multidisciplinary approach to achieve both functional and aesthetic outcomes. This presentation will explore the key considerations in determining whether to retain or extract compromised teeth, and the factors that influence successful rehabilitation in such patients. Emphasis will be placed on the role of digital technology in facilitating comprehensive care planning and enhancing predictability in treatment outcomes. Through clinical case discussions, we will contrast traditional and modern workflows in managing periodontal patients, and examine how to strike the right balance between aesthetics and function. We will also reflect on the continuously evolving philosophy of “less is more” versus “more is less” in treatment planning and how to make evidence-based decisions that support long-term stability. Ultimately, this session aims to guide clinicians in developing thoughtful, patient-centered care strategies that prioritize long-term oral health and satisfaction.
conf-logo
12:10pm-12:35pm
Guided Bone Regeneration: Factors Affecting the Outcome
Nikos Donos 🇬🇧
L3
A prerequisite for the successful placement of dental implants in an ideal, prosthodontically driven position is the presence of a minimum amount of bone height and width at the recipient site that will provide a functional and cosmetic implant borne restoration for the patient. In cases where the amount of bone is not adequate for implant placement, different ridge augmentation procedures have been suggested. In recent years, a number of experimental and clinical studies have demonstrated that following the use of the GBR principle in combination with dental implants, bone regeneration around the exposed implant threads can be achieved. A number of biologic, technical and material related factors have been associated with the final outcome of these procedures. In this presentation, the available evidence provided by a series of experimental and clinical studies will be critically appraised and the healing potential of the GBR principle with or without the combined use bone grafts under different conditions will be evaluated. The critical points of the surgical procedures related to factors affecting the healing outcome will be presented and linked to possible clinical scenarios. Furthermore, the current knowledge based on relevant systematic reviews will also be discussed.
conf-logo
12:35pm-12:55pm
Panel - discussion
Forum
conf-logo
12:55pm-1:00pm
Gift/Photo
conf-logo
1:00pm-2:30pm
LUNCH & TRADE BOOTH VIEWING
conf-logo
2:30pm-2:35pm
Peri-implantitis: Exploring Current Trends and Advancements
Mohd Zamri/Vince Iacono as Moderators
Session 6
conf-logo
2:35pm-3:00pm
Similarity and Difference of Periodontitis and Periimplantitis
Vincent Iacono 🇺🇸
L1
Peri-implantitis, much like periodontitis, is a multifactorial inflammatory disease associated with dysbiotic biofilms. While both conditions share pathogenic mechanisms—including the upregulation of pro-inflammatory cytokines, matrix metalloproteinases (MMPs), and the RANK–RANKL pathway leading to bone loss—the anatomical and biological differences between a tooth and a dental implant significantly affect disease progression. Unlike natural teeth, implants lack a periodontal ligament and its associated connective tissue attachment with Sharpey’s fibers. This structural difference results in a more vulnerable interface between the implant and surrounding tissues. Of particular importance is the circumferential zone of peri-implant soft tissue, which is frequently compromised by dysbiotic biofilms. These microbial challenges often lead to pronounced erythema, suppuration, and a more rapid and aggressive breakdown of bone-to-implant contact compared to periodontitis. Moreover, peri-implant sites may harbor distinct ecological niches, with emerging data suggesting a lower microbial diversity in peri-implantitis lesions compared to periodontal pockets. While both diseases share common risk factors—such as poor oral hygiene, smoking, diabetes, and lack of regular maintenance—peri-implantitis also involves unique contributing elements. These include potential foreign body reactions, anatomical differences in soft and hard tissues, and specific surgical and prosthetic factors. This presentation will explore the complex pathogenesis of peri-implantitis, emphasizing both the shared and distinguishing features from periodontitis. Special attention will be given to the clinical relevance of the peri-implant soft tissue zone and its critical role in disease susceptibility and progression.
conf-logo
3:00pm-3:25pm
New Strategies for Antimicrobial and Surgical Treatment of Peri-implantitis
Jamil Shibli 🇧🇷
L2
The use of dental implants to restore partially and totally edentulous subjects is a successful treatment in Contemporary Dentistry. Overall, the global market for dental implants was valued at US$4 billion in 2024, with over 12 million implants placed. However, the prevalence of biological complications related to dental implant-supported restorations grew simultaneously. The prevalence of peri-implant diseases ranged between 0.4 and 43% after 5 years, and the treatment of this dental biofilm-related infection is currently under active research. Surgical and non-surgical approaches were developed to eliminate the peri-implant infection and to restore the health conditions. Therefore, this lecture will discuss new strategies to overcome peri-implantitis based on antimicrobial and regenerative treatment, and their impact on long-term maintenance. Systemic and local risk conditions that impact peri-implantitis treatment will also be pointed out and discussed based on the evidence-based literature.
conf-logo
3:25pm-3:50pm
Etiology and treatment of soft tissue pathologies around implants
Anton Sculean 🇨🇭
L3
conf-logo
3:50pm-4:10pm
Panel - discussion
Forum
conf-logo
4:10pm-4:15pm
Gift/Photo
conf-logo
4:15pm-4:45pm
Award & Closing Ceremony
conf-logo
7:00pm-10:00pm
Dinner (by invitation only)